158 related articles for article (PubMed ID: 26291519)
1. Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years.
Potosky AL; O'Neill SC; Isaacs C; Tsai HT; Chao C; Liu C; Ekezue BF; Selvam N; Kessler LG; Zhou Y; Schwartz MD
Cancer; 2015 Nov; 121(22):4062-70. PubMed ID: 26291519
[TBL] [Abstract][Full Text] [Related]
2. The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapy.
MacDonald KV; Bombard Y; Deal K; Trudeau M; Leighl N; Marshall DA
Eur J Cancer; 2016 Jul; 61():85-93. PubMed ID: 27155447
[TBL] [Abstract][Full Text] [Related]
3. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
4. The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations.
Panattoni L; Lieu TA; Jayasekera J; O'Neill S; Mandelblatt JS; Etzioni R; Phelps CE; Ramsey SD
Breast Cancer Res Treat; 2019 Jan; 173(2):417-427. PubMed ID: 30306429
[TBL] [Abstract][Full Text] [Related]
5. Real-world economic value of a 21-gene assay in early-stage breast cancer.
Waintraub SE; McNamara D; Graham DMA; Pecora AL; Min J; Wu T; Noh HG; Connors J; Pe Benito R; Choi K; Schultz E; Goldberg SL
Am J Manag Care; 2017 Dec; 23(12):e416-e420. PubMed ID: 29261249
[TBL] [Abstract][Full Text] [Related]
6. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
[TBL] [Abstract][Full Text] [Related]
7. Changes over time in the impact of gene-expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A nationwide study.
Kuijer A; Drukker CA; Elias SG; Smorenburg CH; Th Rutgers EJ; Siesling S; van Dalen T
Int J Cancer; 2016 Aug; 139(4):769-75. PubMed ID: 27062369
[TBL] [Abstract][Full Text] [Related]
8. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
[TBL] [Abstract][Full Text] [Related]
9. Impact of oncotype DX recurrence score in the management of breast cancer cases.
Nguyen MT; Stessin A; Nagar H; D'Alfonso TM; Chen Z; Cigler T; Hayes MK; Shin SJ
Clin Breast Cancer; 2014 Jun; 14(3):182-90. PubMed ID: 24486121
[TBL] [Abstract][Full Text] [Related]
10. How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment.
Marshall DA; Deal K; Bombard Y; Leighl N; MacDonald KV; Trudeau M
BMJ Open; 2016 Jun; 6(6):e010981. PubMed ID: 27256091
[TBL] [Abstract][Full Text] [Related]
11. Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65.
O'Neill SC; Isaacs C; Lynce F; Graham DM; Chao C; Sheppard VB; Zhou Y; Liu C; Selvam N; Schwartz MD; Potosky AL
Breast Cancer Res; 2017 Mar; 19(1):45. PubMed ID: 28359319
[TBL] [Abstract][Full Text] [Related]
12. Impact of gene-expression profiling in patients with early breast cancer when applied outside the guideline directed indication area.
Schreuder K; Kuijer A; Rutgers EJT; Smorenburg CH; van Dalen T; Siesling S
Eur J Cancer; 2017 Oct; 84():270-277. PubMed ID: 28844015
[TBL] [Abstract][Full Text] [Related]
13. Association of 21-gene recurrence score assay and adjuvant chemotherapy use in the medicare population, 2008-2011.
Su KW; Hall J; Soulos PR; Abu-Khalaf MM; Evans SB; Mougalian SS; Rutter CE; Davidoff AJ; Gross CP
J Geriatr Oncol; 2016 Jan; 7(1):15-23. PubMed ID: 26704661
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care.
Haas JS; Liang SY; Hassett MJ; Shiboski S; Elkin EB; Phillips KA
Breast Cancer Res Treat; 2011 Nov; 130(2):619-26. PubMed ID: 21681446
[TBL] [Abstract][Full Text] [Related]
15. The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study.
Kuchel A; Robinson T; Comins C; Shere M; Varughese M; Sparrow G; Sahu A; Saunders L; Bahl A; Cawthorn SJ; Braybrooke JP
Br J Cancer; 2016 Mar; 114(7):731-6. PubMed ID: 26954715
[TBL] [Abstract][Full Text] [Related]
16. Underutilization of gene expression profiling for early-stage breast cancer in California.
Cress RD; Chen YS; Morris CR; Chew H; Kizer KW
Cancer Causes Control; 2016 Jun; 27(6):721-7. PubMed ID: 27097910
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
18. Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.
Levine MN; Julian JA; Bedard PL; Eisen A; Trudeau ME; Higgins B; Bordeleau L; Pritchard KI
J Clin Oncol; 2016 Apr; 34(10):1065-71. PubMed ID: 26598746
[TBL] [Abstract][Full Text] [Related]
19. Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer.
Le Du F; Gonzalez-Angulo AM; Park M; Liu DD; Hortobagyi GN; Ueno NT
Clin Breast Cancer; 2015 Dec; 15(6):458-66. PubMed ID: 26233757
[TBL] [Abstract][Full Text] [Related]
20. Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer.
Rutter CE; Yao X; Mancini BR; Aminawung JA; Chagpar AB; Saglam O; Hofstatter EW; Abu-Khalaf M; Gross CP; Evans SB
Clin Breast Cancer; 2016 Feb; 16(1):59-62. PubMed ID: 26483315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
